Fortress Biotech Inc (FBIO)
1.94
+0.18
(+10.23%)
USD |
NASDAQ |
May 17, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Research and Development Expense (Quarterly): 14.08M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.08M |
| September 30, 2023 | 20.35M |
| June 30, 2023 | 32.14M |
| March 31, 2023 | 39.51M |
| December 31, 2022 | 35.12M |
| September 30, 2022 | 29.90M |
| June 30, 2022 | 33.13M |
| March 31, 2022 | 36.72M |
| December 31, 2021 | 43.05M |
| September 30, 2021 | 28.08M |
| June 30, 2021 | 33.83M |
| March 31, 2021 | 20.15M |
| December 31, 2020 | 17.96M |
| September 30, 2020 | 13.76M |
| June 30, 2020 | 17.27M |
| March 31, 2020 | 15.12M |
| December 31, 2019 | 23.62M |
| September 30, 2019 | 15.27M |
| June 30, 2019 | 18.71M |
| March 31, 2019 | 23.72M |
| December 31, 2018 | 25.05M |
| September 30, 2018 | 19.79M |
| June 30, 2018 | 17.49M |
| March 31, 2018 | 25.06M |
| December 31, 2017 | 14.41M |
| Date | Value |
|---|---|
| September 30, 2017 | 16.19M |
| June 30, 2017 | 13.48M |
| March 31, 2017 | 8.404M |
| December 31, 2016 | 10.58M |
| September 30, 2016 | 8.316M |
| June 30, 2016 | 8.407M |
| March 31, 2016 | 7.819M |
| December 31, 2015 | 5.756M |
| September 30, 2015 | 10.97M |
| June 30, 2015 | 3.959M |
| March 31, 2015 | 9.081M |
| December 31, 2014 | 1.766M |
| September 30, 2014 | 1.609M |
| June 30, 2014 | 2.377M |
| March 31, 2014 | 4.487M |
| December 31, 2013 | 6.552M |
| September 30, 2013 | 5.361M |
| June 30, 2013 | 7.795M |
| March 31, 2013 | 5.974M |
| December 31, 2012 | 5.618M |
| September 30, 2012 | 3.777M |
| June 30, 2012 | 4.525M |
| March 31, 2012 | 4.581M |
| December 31, 2011 | 3.442M |
| September 30, 2011 | 1.753M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
13.76M
Minimum
Sep 2020
43.05M
Maximum
Dec 2021
25.67M
Average
23.62M
Median
Dec 2019
Research and Development Expense (Quarterly) Benchmarks
| Journey Medical Corp | 7.884M |
| Avenue Therapeutics Inc | 0.982M |
| Checkpoint Therapeutics Inc | 8.497M |
| Mustang Bio Inc | 6.677M |
| Viking Therapeutics Inc | 24.10M |